- Home
- WRLD vs EYPT Comparison
WRLD vs EYPT Comparison
Compare WRLD & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRLD
- EYPT
- Stock Information
- Founded
- WRLD 1962
- EYPT N/A
- Country
- WRLD United States
- EYPT
- Employees
- WRLD N/A
- EYPT N/A
- Industry
- WRLD Finance: Consumer Services
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- WRLD Finance
- EYPT Industrials
- Exchange
- WRLD Nasdaq
- EYPT Nasdaq
- Market Cap
- WRLD 859.5M
- EYPT 741.0M
- IPO Year
- WRLD 1991
- EYPT N/A
- Fundamental
- Price
- WRLD $173.01
- EYPT $14.01
- Analyst Decision
- WRLD
- EYPT
- Analyst Count
- WRLD 0
- EYPT 0
- Target Price
- WRLD N/A
- EYPT N/A
- AVG Volume (30 Days)
- WRLD 40.7K
- EYPT 659.8K
- Earning Date
- WRLD 10-24-2025
- EYPT 08-06-2025
- Dividend Yield
- WRLD N/A
- EYPT N/A
- EPS Growth
- WRLD 10.95
- EYPT N/A
- EPS
- WRLD 14.92
- EYPT N/A
- Revenue
- WRLD $567,706,032.00
- EYPT $51,898,000.00
- Revenue This Year
- WRLD N/A
- EYPT N/A
- Revenue Next Year
- WRLD $3.55
- EYPT N/A
- P/E Ratio
- WRLD $11.78
- EYPT N/A
- Revenue Growth
- WRLD 0.80
- EYPT 2.99
- 52 Week Low
- WRLD $104.99
- EYPT $3.91
- 52 Week High
- WRLD $177.25
- EYPT $14.37
- Technical
- Relative Strength Index (RSI)
- WRLD 56.58
- EYPT 77.25
- Support Level
- WRLD $165.28
- EYPT $11.38
- Resistance Level
- WRLD $174.51
- EYPT $12.24
- Average True Range (ATR)
- WRLD 4.92
- EYPT 0.74
- MACD
- WRLD 0.41
- EYPT 0.13
- Stochastic Oscillator
- WRLD 82.66
- EYPT 89.80
About WRLD World Acceptance Corporation
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.